院内感染対策サーベイランス検査部⾨【外来検体】 7．主要 …...2018/03/01 · 7．主要菌の抗菌薬感受性* Staphylococcus aureus(ALL)† 公開情報

7．主要菌の抗菌薬感受性*

Staphylococcus aureus (ALL)†

公開情報 2018年1⽉〜12⽉年報(全集計対象医療機関:1904施設)

2019年07⽉18⽇

186,768 (99.5%)

191,879 (100.0%)

155,143 (65.7%)

222,836 (100.0%)

244,303 (100.0%)

227,414 (92.6%)

194,521 (87.6%)

123,920 (56.2%)

164,238 (70.9%)

207,138 (87.6%)

27,955 (68.9%)

129,025 (69.7%)

69,518 (34.8%)

SorI:3 (0.0%)

I:1,774 (0.8%)

I:13 (0.0%)

I:19 (0.0%)

I:3,894 (1.6%)

I:2,493 (1.1%)

I:7,405 (3.4%)

I:5,262 (2.3%)

I:7,177 (3.0%)

IorR:67 (0.0%)

IorR:22 (0.0%)

IorR:52 (0.0%)

IorR:136 (0.1%)

IorR:149 (0.1%)

IorR:72 (0.0%)

R:760 (0.4%)

R:68 (0.0%)79,315 (33.6%)

R:6 (0.0%)

R:14,343 (5.8%)24,971 (11.2%)

88,857 (40.3%)

61,429 (26.5%)

R:22,135 (9.4%)12,600 (31.0%)

55,769 (30.1%)

130,173 (65.2%)

判定不能:182 (0.1%)

判定不能:1 (0.0%)

判定不能:15 (0.0%)

判定不能:43 (0.0%)

判定不能:581 (0.3%)

判定不能:16 (0.0%)

判定不能:28 (0.1%)

判定不能:281 (0.2%)

判定不能:1 (0.0%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

PCG (N=199,692)

MPIPC (N=185,075)

CFX (N=40,583)

CEZ (N=236,538)

GM (N=231,659)

EM (N=220,321)

CLDM (N=222,080)

MINO (N=245,673)

VCM (N=244,322)

TEIC (N=222,870)

LVFX (N=236,299)

LZD (N=191,948)

ST (N=187,710)

感性(S) SorI 中間(I) IorR 耐性(R) 判定不能

46,171 (99.9%)NS:66 (0.1%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

DAP (N=46,237)

感性(S) ⾮感性(NS) 判定不能

外来検体で、かつ検査法が微量液体希釈法⼜はEtestと設定されMIC値が報告されている検体を集計抗菌薬感受性結果の重複処理(巻末参照)が⾏われている*S,I,RまたはS,NSの判定はCLSI 2012 (M100-S22）に準拠†菌名コード︓1301, 1303〜1306と報告された菌集計株数が30株未満の場合には、集計結果を公表しない

1

院内感染対策サーベイランス検査部⾨

本公表データは国内の全医療機関の数値を集計したデータではありません。データ集計⽇: 2019年04⽉16⽇

公開情報掲載⽇:

【外来検体】


Staphylococcus aureus (MSSA)†

117,064 (99.5%)

127,109 (85.6%)

153,395 (99.0%)

134,692 (96.4%)

101,329 (72.9%)

111,583 (76.4%)

137,688 (100.0%)

21,500 (99.9%)

149,734 (99.9%)

63,029 (49.6%)

SorI:3 (0.0%)

I:1,406 (0.9%)

I:505 (0.3%)

I:1,121 (0.8%)

I:3,980 (2.9%)

I:3,130 (2.1%)

I:11 (0.0%)

I:43 (0.0%)

IorR:24 (0.0%)

IorR:3 (0.0%)

IorR:10 (0.0%)

IorR:48 (0.0%)

IorR:83 (0.1%)

IorR:2 (0.0%)

R:427 (0.4%)

19,878 (13.4%)

R:969 (0.6%)

R:3,928 (2.8%)

33,597 (24.2%)

30,820 (21.1%)

R:33 (0.0%)

R:20 (0.1%)

R:40 (0.0%)

64,082 (50.4%)

判定不能:103 (0.1%)

判定不能:24 (0.0%)

判定不能:407 (0.3%)

判定不能:1 (0.0%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

PCG (N=127,112)

CEZ (N=149,819)

CVA/AMPC (N=21,520)

IPM (N=137,732)

GM (N=146,023)

EM (N=138,957)

CLDM (N=139,775)

MINO (N=154,872)

LVFX (N=148,417)

ST (N=117,594)


公開情報 2018年1⽉〜12⽉年報(全集計対象医療機関)

2019年07⽉18⽇

外来検体で、かつ検査法が微量液体希釈法⼜はEtestと設定されMIC値が報告されている検体を集計抗菌薬感受性結果の重複処理(巻末参照)が⾏われている*S,I,Rの判定はCLSI 2012 (M100-S22）に準拠†菌名コード︓1304, 1305, 1306と報告された菌、または菌名コード︓1301と報告され抗菌薬コード︓1208（オキサシリン）および抗菌薬コード︓1606（セフォキシチン）の感受性結果「S」の菌（⼀⽅が「S」で他⽅が未測定の場合を含む）集計株数が30株未満の場合には、集計結果を公表しない

2




【外来検体】


Staphylococcus aureus (MRSA)†


2019年07⽉18⽇

63,036 (100.0%)

58,966 (99.3%)

15,083 (20.2%)

72,410 (100.0%)

78,164 (100.0%)

60,336 (77.8%)

47,090 (67.4%)

12,205 (17.7%)

42,497 (58.1%)

I:233 (0.3%)

I:7 (0.0%)

I:8 (0.0%)

I:3,479 (4.5%)

I:1,272 (1.8%)

I:3,056 (4.4%)

I:1,826 (2.5%)

IorR:45 (0.1%)

IorR:20 (0.0%)

IorR:34 (0.0%)

IorR:82 (0.1%)

IorR:64 (0.1%)

R:20 (0.0%)

R:330 (0.6%)

59,196 (79.4%)

R:4 (0.0%)

13,755 (17.7%)

21,460 (30.7%)

53,613 (77.7%)

28,548 (39.0%)

判定不能:1 (0.0%)

判定不能:82 (0.1%)

判定不能:4 (0.0%)

判定不能:20 (0.0%)

判定不能:180 (0.2%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

GM (N=73,115)

EM (N=68,956)

CLDM (N=69,876)

MINO (N=77,590)

VCM (N=78,172)

TEIC (N=72,425)

LVFX (N=74,557)

ST (N=59,378)

LZD (N=63,057)


14,742 (99.8%)NS:28 (0.2%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

DAP (N=14,770)


外来検体で、かつ検査法が微量液体希釈法⼜はEtestと設定されMIC値が報告されている検体を集計抗菌薬感受性結果の重複処理(巻末参照)が⾏われている*S,I,RまたはS,NSの判定はCLSI 2012 (M100-S22）に準拠†菌名コード︓1303と報告された菌、または菌名コード︓1301と報告され抗菌薬コード︓1208（オキサシリン）または抗菌薬コード︓1606（セフォキシチン）の感受性結果「R」の菌集計株数が30株未満の場合には、集計結果を公表しない

3




【外来検体】


Staphylococcus epidermidis†

41,403 (97.1%)

46,738 (100.0%)

17,065 (48.3%)

9,897 (26.3%)

I:1,186 (2.8%)

I:1 (0.0%)

IorR:2 (0.0%) R:59 (0.1%)

R:3 (0.0%)

18,227 (51.6%)

27,724 (73.7%)

判定不能:1 (0.0%)

判定不能:27 (0.1%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

PCG (N=37,621)

MPIPC (N=35,319)

VCM (N=46,742)

TEIC (N=42,651)



2019年07⽉18⽇

外来検体で、かつ検査法が微量液体希釈法⼜はEtestと設定されMIC値が報告されている検体を集計抗菌薬感受性結果の重複処理(巻末参照)が⾏われている*S,I,Rの判定はCLSI 2012 (M100-S22）に準拠†菌名コード︓1312と報告された菌集計株数が30株未満の場合には、集計結果を公表しない

4




【外来検体】


Coagulase-negative staphylococci (CNS)†

51,548 (98.9%)

58,416 (100.0%)

23,356 (54.1%)

17,470 (39.9%)

I:468 (0.9%)

I:5 (0.0%)

R:83 (0.2%)

R:12 (0.0%)

19,783 (45.8%)

26,337 (60.1%)

判定不能:30 (0.1%)

判定不能:2 (0.0%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

PCG (N=43,809)

MPIPC (N=43,169)

VCM (N=58,433)

TEIC (N=52,099)



2019年07⽉18⽇

外来検体で、かつ検査法が微量液体希釈法⼜はEtestと設定されMIC値が報告されている検体を集計抗菌薬感受性結果の重複処理(巻末参照)が⾏われている*S,I,Rの判定はCLSI 2012 (M100-S22）に準拠†菌名コード︓1311, 1313〜1325と報告された菌（1312︓Staphylococcus epidermidisは対象外）集計株数が30株未満の場合には、集計結果を公表しない

5




【外来検体】


Enterococcus faecalis†

62,178 (89.8%)

64,765 (100.0%)

72,541 (100.0%)

19,616 (27.6%)

S:7,958 (14.2%)

68,237 (99.9%)

58,402 (98.8%)

I:968 (1.4%)

I:2 (0.0%)

I:8 (0.0%)

12,970 (18.3%)

17,186 (30.8%)

IorR:17 (0.0%)

IorR:66 (0.1%)

IorR:56 (0.1%)

R:6,089 (8.8%)

R:9 (0.0%)

R:5 (0.0%)

38,385 (54.0%)

30,649 (54.9%)

R:76 (0.1%)

R:396 (0.7%)

判定不能:1 (0.0%)

判定不能:2 (0.0%)

判定不能:2 (0.0%)

判定不能:2 (0.0%)

判定不能:325 (0.5%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

PCG (N=59,123)

ABPC (N=68,313)

EM (N=55,851)

MINO (N=71,039)

VCM (N=72,556)

TEIC (N=64,777)

LVFX (N=69,252)



2019年07⽉18⽇

外来検体で、かつ検査法が微量液体希釈法⼜はEtestと設定されMIC値が報告されている検体を集計抗菌薬感受性結果の重複処理(巻末参照)が⾏われている*S,I,Rの判定はCLSI 2012 (M100-S22）に準拠†菌名コード︓1201, 1202と報告された菌集計株数が30株未満の場合には、集計結果を公表しない

6




【外来検体】


Enterococcus faecium†

7,169 (99.0%)

S:1,279 (14.8%)

8,344 (99.4%)

9,095 (99.1%)

3,691 (41.5%)

S:657 (9.2%)

1,613 (18.7%)

1,283 (17.0%)

I:73 (1.0%)

I:321 (3.7%)

I:6 (0.1%)

I:21 (0.2%)

2,192 (24.7%)

936 (13.1%)

IorR:18 (0.2%)

IorR:13 (0.1%)

IorR:17 (0.2%)

R:3 (0.0%)

7,032 (81.3%)

R:47 (0.6%)

R:61 (0.7%)

2,989 (33.6%)

5,526 (77.4%)

7,004 (81.1%)

6,147 (81.6%)

判定不能:17 (0.2%)

判定不能:100 (1.3%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

PCG (N=7,530)

ABPC (N=8,634)

EM (N=7,136)

MINO (N=8,885)

VCM (N=9,177)

TEIC (N=8,397)

LVFX (N=8,650)

LZD (N=7,245)



2019年07⽉18⽇

外来検体で、かつ検査法が微量液体希釈法⼜はEtestと設定されMIC値が報告されている検体を集計抗菌薬感受性結果の重複処理(巻末参照)が⾏われている*S,I,Rの判定はCLSI 2012 (M100-S22）に準拠†菌名コード︓1205, 1206と報告された菌集計株数が30株未満の場合には、集計結果を公表しない

7




【外来検体】


Streptococcus pneumoniae(髄液検体)†


2019年07⽉18⽇

167 (98.8%)

47 (38.2%)

S:18 (12.9%)

166 (96.0%)

148 (93.1%)

126 (70.0%)

I:5 (4.1%)

I:5 (3.6%)

I:3 (1.7%)

I:9 (5.7%)

R:2 (1.2%)

71 (57.7%)

117 (83.6%)

R:4 (2.3%)

R:2 (1.3%)

54 (30.0%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

PCG (N=180)

CTX (N=159)

MEPM (N=173)

EM (N=140)

CLDM (N=123)

LVFX (N=169)


172 (100.0%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

VCM (N=172)


外来検体で、かつ検査法が微量液体希釈法⼜はEtestと設定されMIC値が報告されている検体を集計抗菌薬感受性結果の重複処理(巻末参照)が⾏われている*S,I,RまたはS,NSの判定はCLSI 2012 (M100-S22）に準拠†菌名コード︓1131と報告された菌集計株数が30株未満の場合には、集計結果を公表しない

8




【外来検体】


Streptococcus pneumoniae(髄液検体以外)†


2019年07⽉18⽇

57,065 (97.3%)

21,157 (46.7%)

7,489 (15.9%)

49,213 (85.2%)

46,981 (98.4%)

57,853 (98.7%)

SorI:2 (0.0%)

I:259 (0.4%)

I:943 (2.1%)

I:1,293 (2.7%)

I:5,438 (9.4%)

I:436 (0.9%)

I:663 (1.1%)

IorR:14 (0.0%)

IorR:128 (0.3%)

IorR:188 (0.4%)

IorR:5 (0.0%)

R:1,313 (2.2%)

23,053 (50.9%)

38,087 (80.9%)

R:3,101 (5.4%)

R:315 (0.7%)

R:117 (0.2%)

判定不能:2 (0.0%)

判定不能:2 (0.0%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

PCG (N=58,640)

CTX (N=47,732)

MEPM (N=57,752)

EM (N=47,057)

CLDM (N=45,285)

LVFX (N=58,651)


54,926 (100.0%)判定不能:4 (0.0%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

VCM (N=54,930)



9




【外来検体】


Streptococcus pyogenes†


2019年07⽉18⽇

10,423 (87.8%)

6,970 (66.0%)

SorI:77 (0.6%)

SorI:9 (0.1%)

I:56 (0.5%)

I:46 (0.4%)

IorR:15 (0.1%)

IorR:21 (0.2%)

1,301 (11.0%)

3,521 (33.3%)

判定不能:1 (0.0%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

EM (N=10,568)

CLDM (N=11,872)


9,792 (100.0%)

12,781 (99.8%)

12,864 (100.0%)

判定不能:32 (0.2%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

PCG (N=12,864)

ABPC (N=12,813)

CTX (N=9,792)



10




【外来検体】


Streptococcus agalactiae†


2019年07⽉18⽇

38,208 (78.4%)

29,238 (64.4%)

SorI:1,464 (3.0%)

SorI:351 (0.8%)

I:895 (1.8%)

I:1,530 (3.4%)

IorR:8 (0.0%)

IorR:14 (0.0%)

8,130 (16.7%)

14,295 (31.5%)

判定不能:1 (0.0%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

EM (N=45,429)

CLDM (N=48,705)


36,837 (99.3%)

54,537 (99.1%)

53,819 (98.3%)

NS:254 (0.7%)

NS:247 (0.4%)

NS:900 (1.6%)

判定不能:271 (0.5%)

判定不能:3 (0.0%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

PCG (N=54,722)

ABPC (N=55,055)

CTX (N=37,091)



11




【外来検体】


Escherichia coli†

214,728 (68.5%)

313,560 (99.9%)

312,168 (99.5%)

281,674 (99.4%)

207,875 (85.7%)

248,284 (89.4%)

274,335 (89.9%)

188,558 (81.8%)

302,129 (98.6%)

67,854 (22.5%)

217,982 (98.9%)

189,367 (63.3%)

172,931 (58.7%)

SorI:2 (0.0%)

SorI:112 (0.0%)

SorI:1,102 (0.5%)

SorI:1,976 (0.6%)

SorI:44 (0.0%)

SorI:1,544 (0.5%)

140,834 (46.8%)

SorI:88 (0.0%)

I:5,914 (1.9%)

I:301 (0.1%)

I:26 (0.0%)

I:150 (0.1%)

I:5,912 (2.4%)

I:2,974 (1.1%)

I:8,573 (2.8%)

I:851 (0.4%)

I:1,618 (0.5%)

I:8,665 (2.9%)

I:1,353 (0.6%)

I:8,672 (2.9%)

I:2,494 (0.8%)

IorR:305 (0.1%)

IorR:2 (0.0%)

IorR:24 (0.0%)

IorR:161 (0.1%)

IorR:11 (0.0%)

IorR:127 (0.1%)

IorR:31 (0.0%)

IorR:169 (0.1%)

IorR:3 (0.0%)

IorR:333 (0.1%)

IorR:360 (0.1%)

92,462 (29.5%)

R:158 (0.1%)

R:73 (0.0%)

R:46 (0.0%)

27,554 (11.4%)

26,329 (9.5%)

R:19,979 (6.6%)

39,083 (17.0%)

R:1,080 (0.4%)

74,062 (24.6%)

R:966 (0.4%)

100,986 (33.7%)

118,773 (40.3%)

判定不能:1 (0.0%)

判定不能:1,383 (0.4%)

判定不能:1,376 (0.5%)

判定不能:24 (0.0%)

判定不能:127 (0.0%)

判定不能:142 (0.0%)

判定不能:1,764 (0.8%)

判定不能:9,510 (3.2%)

判定不能:1 (0.0%)

判定不能:37 (0.0%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

ABPC (N=294,595)

PIPC (N=299,358)

TAZ/PIPC (N=220,393)

CEZ (N=301,094)

CMZ (N=306,402)

CTX (N=230,427)

CAZ (N=305,016)

CFPM (N=277,875)

AZT (N=242,491)

IPM (N=283,358)

MEPM (N=313,652)

AMK (N=314,022)

LVFX (N=313,409)



2019年07⽉18⽇

外来検体で、かつ検査法が微量液体希釈法⼜はEtestと設定されMIC値が報告されている検体を集計抗菌薬感受性結果の重複処理(巻末参照)が⾏われている*S,I,Rの判定はCLSI 2012 (M100-S22）に準拠†菌名コード︓2001〜2007と報告された菌集計株数が30株未満の場合には、集計結果を公表しない

12




【外来検体】


Klebsiella pneumoniae†

88,521 (97.7%)

91,743 (99.9%)

91,270 (99.5%)

82,805 (99.2%)

69,812 (95.7%)

80,559 (97.2%)

86,724 (96.6%)

64,726 (94.4%)

88,630 (98.6%)

25,178 (28.7%)

64,708 (98.7%)

62,769 (72.2%)

S:4,604 (5.4%)

SorI:1 (0.0%)

SorI:15 (0.0%)

SorI:353 (0.5%)

SorI:599 (0.7%)

SorI:19 (0.0%)

SorI:534 (0.6%)

51,368 (58.6%)

SorI:21 (0.0%)

SorI:1 (0.0%)

I:670 (0.7%)

I:32 (0.0%)

I:17 (0.0%)

I:185 (0.2%)

I:342 (0.5%)

I:262 (0.3%)

I:426 (0.5%)

I:106 (0.2%)

I:218 (0.2%)

I:1,569 (1.8%)

I:387 (0.6%)

11,450 (13.2%)

16,805 (19.6%)

IorR:6 (0.0%)

IorR:1 (0.0%)

IorR:17 (0.0%)

IorR:1 (0.0%)

IorR:11 (0.0%)

IorR:11 (0.0%)

IorR:16 (0.0%)

IorR:2 (0.0%)

IorR:36 (0.0%)

IorR:198 (0.2%)

R:1,405 (1.6%)

R:40 (0.0%)

R:76 (0.1%)

R:54 (0.1%)

R:2,426 (3.3%)

R:2,025 (2.4%)

R:2,003 (2.2%)

R:3,171 (4.6%)

R:513 (0.6%)

R:6,089 (6.9%)

R:474 (0.7%)

12,738 (14.6%)

64,236 (74.8%)

判定不能:383 (0.4%)

判定不能:384 (0.5%)

判定不能:1 (0.0%)

判定不能:13 (0.0%)

判定不能:21 (0.0%)

判定不能:514 (0.7%)

3,421 (3.9%)

判定不能:2 (0.0%)

判定不能:31 (0.0%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

ABPC (N=85,874)

PIPC (N=86,996)

TAZ/PIPC (N=65,592)

CEZ (N=87,641)

CMZ (N=89,906)

CTX (N=68,547)

CAZ (N=89,774)

CFPM (N=82,876)

AZT (N=72,935)

IPM (N=83,443)

MEPM (N=91,747)

AMK (N=91,815)

LVFX (N=90,602)



2019年07⽉18⽇


13




【外来検体】


Enterobacter cloacae†

19,278 (96.0%)

20,290 (99.9%)

20,225 (99.2%)

17,665 (95.4%)

13,885 (85.8%)

17,948 (97.9%)

17,188 (86.6%)

12,283 (81.0%)

S:2,007 (10.1%)

S:231 (1.2%)

13,633 (92.7%)

16,656 (86.7%)

S:2,798 (14.7%)

SorI:1 (0.0%)

SorI:7 (0.0%)

SorI:56 (0.3%)

SorI:57 (0.3%)

SorI:4 (0.0%)

SorI:17 (0.1%)

SorI:323 (1.6%)

SorI:3 (0.0%)

I:323 (1.6%)

I:14 (0.1%)

I:24 (0.1%)

I:667 (3.6%)

I:402 (2.5%)

I:132 (0.7%)

I:368 (1.9%)

I:382 (2.5%)

I:1,423 (7.2%)

I:124 (0.6%)

I:557 (3.8%)

I:754 (3.9%)

2,998 (15.7%)

IorR:3 (0.0%)

IorR:4 (0.0%)

IorR:6 (0.0%)

IorR:196 (1.0%)

IorR:26 (0.1%)

IorR:1 (0.0%)

IorR:2 (0.0%)

IorR:32 (0.2%)

R:472 (2.4%)

R:15 (0.1%)

R:61 (0.3%)

R:103 (0.6%)

1,836 (11.3%)

R:233 (1.3%)

2,234 (11.3%)

2,386 (15.7%)

16,140 (81.6%)

19,033 (96.3%)

R:513 (3.5%)

1,796 (9.4%)

13,232 (69.4%)

判定不能:74 (0.4%)

判定不能:73 (0.4%)

判定不能:2 (0.0%)

判定不能:12 (0.1%)

判定不能:5 (0.0%)

判定不能:99 (0.7%)

判定不能:1 (0.0%)

判定不能:20 (0.1%)

判定不能:1 (0.0%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

ABPC (N=19,061)

PIPC (N=19,208)

TAZ/PIPC (N=14,707)

CEZ (N=19,757)

CMZ (N=19,784)

CTX (N=15,160)

CAZ (N=19,852)

CFPM (N=18,329)

AZT (N=16,181)

IPM (N=18,515)

MEPM (N=20,385)

AMK (N=20,319)

LVFX (N=20,076)



2019年07⽉18⽇


14




【外来検体】


Klebsiella aerogenes（旧名︓Enterobacter aerogenes）†

12,120 (99.0%)

12,399 (99.9%)

12,423 (99.6%)

9,384 (84.7%)

8,895 (89.4%)

11,144 (99.3%)

10,650 (87.7%)

7,761 (84.0%)

S:1,061 (8.8%)

S:197 (1.6%)

8,344 (92.5%)

10,301 (87.3%)

S:1,611 (13.7%)

SorI:7 (0.1%)

SorI:30 (0.3%)

SorI:70 (0.6%)

SorI:3 (0.0%)

SorI:23 (0.2%)

SorI:715 (5.9%)

SorI:1 (0.0%)

I:60 (0.5%)

I:4 (0.0%)

I:3 (0.0%)

1,437 (13.0%)

I:297 (3.0%)

I:11 (0.1%)

I:218 (1.8%)

I:128 (1.4%)

I:821 (6.8%)

I:125 (1.0%)

I:493 (5.5%)

I:743 (6.3%)

1,799 (15.3%)

IorR:1 (0.0%)

IorR:1 (0.0%)

IorR:3 (0.0%)

IorR:1 (0.0%)

IorR:6 (0.1%)

IorR:121 (1.0%)

IorR:25 (0.2%)

IorR:1 (0.0%)

IorR:1 (0.0%)

IorR:32 (0.3%)

R:67 (0.5%)

R:7 (0.1%)

R:11 (0.1%)

R:213 (1.9%)

R:728 (7.3%)

R:53 (0.5%)

1,204 (9.9%)

1,272 (13.8%)

10,068 (83.2%)

11,069 (91.1%)

R:178 (2.0%)

R:761 (6.4%)

8,286 (70.6%)

判定不能:34 (0.3%)

判定不能:34 (0.3%)

判定不能:1 (0.0%)

判定不能:6 (0.1%)

判定不能:3 (0.0%)

判定不能:64 (0.7%)

判定不能:23 (0.2%)

判定不能:6 (0.1%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

ABPC (N=11,734)

PIPC (N=11,806)

TAZ/PIPC (N=9,017)

CEZ (N=12,154)

CMZ (N=12,094)

CTX (N=9,234)

CAZ (N=12,146)

CFPM (N=11,217)

AZT (N=9,951)

IPM (N=11,076)

MEPM (N=12,471)

AMK (N=12,410)

LVFX (N=12,248)



2019年07⽉18⽇

外来検体で、かつ検査法が微量液体希釈法⼜はEtestと設定されMIC値が報告されている検体を集計抗菌薬感受性結果の重複処理(巻末参照)が⾏われている*S,I,Rの判定はCLSI 2012 (M100-S22）に準拠†菌名コード︓2152と報告された菌（旧名︓Enterobacter aerogenes）集計株数が30株未満の場合には、集計結果を公表しない

15




【外来検体】


Citrobacter freundii†

10,132 (95.0%)

10,643 (99.8%)

10,618 (99.5%)

9,310 (96.3%)

7,152 (86.7%)

9,488 (98.9%)

8,994 (87.1%)

6,567 (84.4%)

5,020 (48.5%)

S:102 (1.0%)

7,225 (95.3%)

8,638 (84.6%)

3,450 (35.1%)

SorI:5 (0.1%)

SorI:29 (0.4%)

SorI:66 (0.6%)

SorI:36 (0.3%)

SorI:340 (3.3%)

SorI:3 (0.0%)

I:233 (2.2%)

I:8 (0.1%)

I:297 (3.1%)

I:201 (2.4%)

I:22 (0.2%)

I:149 (1.4%)

I:124 (1.6%)

3,074 (29.7%)

I:117 (1.1%)

I:241 (3.2%)

I:449 (4.4%)

1,641 (16.7%)

IorR:2 (0.0%)

IorR:1 (0.0%)

IorR:1 (0.0%)

IorR:1 (0.0%)

IorR:1 (0.0%)

IorR:6 (0.1%)

IorR:50 (0.5%)

IorR:9 (0.1%)

IorR:1 (0.0%)

IorR:4 (0.0%)

IorR:18 (0.2%)

R:299 (2.8%)

R:10 (0.1%)

R:12 (0.1%)

R:22 (0.2%)

868 (10.5%)

R:73 (0.8%)

1,118 (10.8%)

1,038 (13.3%)

2,160 (20.9%)

9,725 (94.2%)

R:112 (1.5%)

1,120 (11.0%)

4,731 (48.1%)

判定不能:38 (0.4%)

判定不能:38 (0.4%)

判定不能:2 (0.0%)

判定不能:12 (0.1%)

判定不能:2 (0.0%)

判定不能:50 (0.6%)

判定不能:33 (0.3%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

ABPC (N=9,840)

PIPC (N=10,211)

TAZ/PIPC (N=7,582)

CEZ (N=10,326)

CMZ (N=10,340)

CTX (N=7,785)

CAZ (N=10,330)

CFPM (N=9,596)

AZT (N=8,253)

IPM (N=9,672)

MEPM (N=10,668)

AMK (N=10,662)

LVFX (N=10,666)



2019年07⽉18⽇


16




【外来検体】


Citrobacter koseri†

9,516 (94.4%)

10,127 (99.9%)

10,093 (99.8%)

9,026 (99.5%)

7,247 (93.4%)

8,768 (96.4%)

9,285 (94.6%)

6,689 (93.1%)

9,584 (96.3%)

2,859 (29.8%)

6,974 (97.5%)

3,696 (38.8%)

S:78 (0.8%)

SorI:1 (0.0%)

SorI:13 (0.2%)

SorI:46 (0.5%)

SorI:1 (0.0%)

SorI:36 (0.4%)

5,403 (56.4%)

SorI:2 (0.0%)

I:64 (0.6%)

I:7 (0.1%)

I:1 (0.0%)

I:22 (0.2%)

I:38 (0.5%)

I:26 (0.3%)

I:73 (0.7%)

I:28 (0.4%)

I:155 (1.6%)

I:230 (2.4%)

I:76 (1.1%)

3,490 (36.6%)

I:436 (4.7%)

IorR:4 (0.0%)

IorR:1 (0.0%)

IorR:5 (0.1%)

IorR:2 (0.0%)

IorR:13 (0.1%)

R:500 (5.0%)

R:6 (0.1%)

R:3 (0.0%)

R:6 (0.1%)

R:460 (5.9%)

R:295 (3.2%)

R:401 (4.1%)

R:439 (6.1%)

R:172 (1.7%)

R:768 (8.0%)

R:99 (1.4%)

2,342 (24.6%)

8,837 (94.4%)

判定不能:17 (0.2%)

判定不能:17 (0.2%)

判定不能:11 (0.1%)

判定不能:30 (0.4%)

322 (3.4%)

判定不能:1 (0.0%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

ABPC (N=9,364)

PIPC (N=9,528)

TAZ/PIPC (N=7,152)

CEZ (N=9,584)

CMZ (N=9,952)

CTX (N=7,188)

CAZ (N=9,816)

CFPM (N=9,093)

AZT (N=7,758)

IPM (N=9,072)

MEPM (N=10,114)

AMK (N=10,140)

LVFX (N=10,080)



2019年07⽉18⽇


17




【外来検体】


Proteus mirabilis†

18,196 (85.7%)

21,343 (99.7%)

21,248 (99.5%)

4,387 (49.1%)

15,662 (94.0%)

17,838 (93.1%)

20,465 (98.4%)

13,849 (88.3%)

20,673 (99.1%)

S:2,983 (14.6%)

15,040 (99.7%)

17,049 (84.1%)

16,028 (79.6%)

SorI:409 (4.6%)

SorI:80 (0.5%)

SorI:156 (0.7%)

SorI:2 (0.0%)

SorI:86 (0.4%)

10,117 (49.4%)

SorI:11 (0.1%)

I:1,172 (5.5%)

I:48 (0.2%)

I:2 (0.0%)

2,045 (22.9%)

I:104 (0.6%)

I:107 (0.6%)

I:78 (0.4%)

I:62 (0.4%)

I:44 (0.2%)

2,581 (12.6%)

I:22 (0.1%)

I:404 (2.0%)

I:132 (0.7%)

IorR:22 (0.1%)

IorR:7 (0.0%)

IorR:19 (0.1%)

IorR:1 (0.0%)

IorR:13 (0.1%)

IorR:2 (0.0%)

IorR:14 (0.1%)

IorR:17 (0.1%)

IorR:23 (0.1%)

R:1,833 (8.6%)

R:11 (0.1%)

R:4 (0.0%)

2,008 (22.5%)

R:802 (4.8%)

R:1,188 (6.2%)

R:104 (0.5%)

1,624 (10.4%)

R:61 (0.3%)

3,962 (19.4%)

R:14 (0.1%)

2,797 (13.8%)

3,940 (19.6%)

判定不能:2 (0.0%)

判定不能:92 (0.4%)

判定不能:93 (1.0%)

判定不能:1 (0.0%)

判定不能:130 (0.8%)

807 (3.9%)

判定不能:3 (0.0%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

ABPC (N=20,126)

PIPC (N=20,267)

TAZ/PIPC (N=15,087)

CEZ (N=20,464)

CMZ (N=20,866)

CTX (N=15,680)

CAZ (N=20,805)

CFPM (N=19,152)

AZT (N=16,655)

IPM (N=8,942)

MEPM (N=21,346)

AMK (N=21,404)

LVFX (N=21,223)



2019年07⽉18⽇


18




【外来検体】


Proteus vulgaris†

5,241 (98.6%)

5,296 (99.8%)

5,274 (99.4%)

1,590 (54.6%)

3,763 (87.4%)

4,757 (98.3%)

5,035 (97.0%)

3,081 (76.8%)

5,123 (99.0%)

S:18 (0.3%)

3,899 (99.3%)

3,536 (70.6%)

S:281 (5.6%)

SorI:1 (0.0%)

SorI:21 (0.5%)

SorI:61 (1.2%)

SorI:1 (0.0%)

SorI:18 (0.3%)

SorI:114 (2.2%)

SorI:4 (0.1%)

I:35 (0.7%)

I:3 (0.1%)

I:2 (0.0%)

686 (23.6%)

I:80 (1.9%)

I:26 (0.5%)

I:47 (0.9%)

I:160 (4.0%)

I:19 (0.4%)

I:21 (0.4%)

I:17 (0.4%)

720 (14.4%)

I:66 (1.3%)

IorR:1 (0.0%)

IorR:1 (0.0%)

IorR:2 (0.0%)

IorR:1 (0.0%)

IorR:10 (0.2%)

IorR:1 (0.0%)

IorR:12 (0.2%)

R:38 (0.7%)

R:6 (0.1%)

604 (20.8%)

441 (10.2%)

R:54 (1.1%)

R:49 (0.9%)

740 (18.4%)

R:15 (0.3%)

4,981 (96.7%)

R:5 (0.1%)

749 (15.0%)

4,636 (92.8%)

判定不能:29 (0.5%)

判定不能:28 (1.0%)

判定不能:2 (0.0%)

判定不能:28 (0.7%)

判定不能:5 (0.1%)

判定不能:2 (0.0%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

ABPC (N=4,997)

PIPC (N=5,006)

TAZ/PIPC (N=3,925)

CEZ (N=5,149)

CMZ (N=5,176)

CTX (N=4,012)

CAZ (N=5,192)

CFPM (N=4,839)

AZT (N=4,306)

IPM (N=2,910)

MEPM (N=5,305)

AMK (N=5,305)

LVFX (N=5,314)



2019年07⽉18⽇


19




【外来検体】


Serratia marcescens†

13,783 (94.4%)

14,587 (99.4%)

14,627 (99.4%)

11,438 (94.4%)

10,558 (89.0%)

13,251 (98.9%)

12,924 (89.8%)

3,901 (83.7%)

11,581 (82.1%)

S:7 (0.0%)

9,426 (90.4%)

11,842 (85.0%)

S:1,001 (7.3%)

SorI:7 (0.1%)

SorI:44 (0.4%)

SorI:89 (0.6%)

SorI:2 (0.0%)

SorI:57 (0.4%)

SorI:16 (0.1%)

SorI:2 (0.0%)

I:420 (2.9%)

I:56 (0.4%)

I:14 (0.1%)

I:487 (4.0%)

I:303 (2.6%)

I:53 (0.4%)

I:195 (1.4%)

I:179 (3.8%)

I:1,210 (8.6%)

I:4 (0.0%)

I:646 (6.2%)

1,284 (9.2%)

1,947 (14.2%)

IorR:3 (0.0%)

IorR:2 (0.0%)

IorR:1 (0.0%)

IorR:1 (0.0%)

IorR:2 (0.0%)

IorR:29 (0.2%)

IorR:21 (0.1%)

IorR:3 (0.0%)

IorR:5 (0.0%)

IorR:37 (0.3%)

R:387 (2.7%)

R:35 (0.2%)

R:18 (0.1%)

R:123 (1.0%)

R:952 (8.0%)

R:79 (0.6%)

R:1,176 (8.2%)

513 (11.0%)

R:1,228 (8.7%)

14,248 (99.7%)

R:347 (3.3%)

R:805 (5.8%)

10,678 (78.1%)

判定不能:62 (0.4%)

判定不能:62 (0.5%)

判定不能:1 (0.0%)

判定不能:18 (0.1%)

判定不能:1 (0.0%)

判定不能:66 (1.4%)

判定不能:1 (0.0%)

判定不能:4 (0.0%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

ABPC (N=13,667)

PIPC (N=13,936)

TAZ/PIPC (N=10,424)

CEZ (N=14,297)

CMZ (N=14,105)

CTX (N=4,663)

CAZ (N=14,386)

CFPM (N=13,402)

AZT (N=11,860)

IPM (N=12,117)

MEPM (N=14,721)

AMK (N=14,678)

LVFX (N=14,593)



2019年07⽉18⽇


20




【外来検体】


Pseudomonas aeruginosa†

63,728 (89.3%)

72,823 (97.8%)

60,555 (89.8%)

70,141 (94.6%)

62,897 (91.3%)

65,262 (93.5%)

51,640 (83.7%)

69,122 (94.6%)

54,930 (93.7%)

67,192 (91.4%)

SorI:251 (0.3%)

SorI:248 (0.4%)

SorI:20 (0.0%)

I:3,008 (4.2%)

I:999 (1.3%)

I:5,125 (7.6%)

I:1,526 (2.1%)

I:1,803 (2.6%)

I:2,827 (4.0%)

5,952 (9.6%)

I:1,740 (2.4%)

I:2,203 (3.8%)

I:3,732 (5.1%)

IorR:25 (0.0%)

IorR:4 (0.0%)

IorR:3 (0.0%)

IorR:37 (0.0%)

IorR:88 (0.1%)

IorR:6 (0.0%)

IorR:154 (0.2%)

IorR:82 (0.1%)

IorR:7 (0.0%)

IorR:17 (0.0%)

R:4,575 (6.4%)

R:670 (0.9%)

R:1,731 (2.6%)

R:2,202 (3.0%)

R:3,880 (5.6%)

R:1,730 (2.5%)

R:3,839 (6.2%)

R:2,117 (2.9%)

R:1,488 (2.5%)

R:2,562 (3.5%)

判定不能:1 (0.0%)

判定不能:1 (0.0%)

判定不能:2 (0.0%)

判定不能:106 (0.2%)

判定不能:8 (0.0%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

PIPC (N=73,503)

TAZ/PIPC (N=58,648)

CAZ (N=73,069)

AZT (N=61,691)

CFPM (N=69,827)

IPM (N=68,916)

MEPM (N=74,157)

GM (N=67,414)

AMK (N=74,497)

LVFX (N=71,337)



2019年07⽉18⽇


21




【外来検体】


Acinetobacter spp.†

8,417 (94.2%)

10,491 (95.1%)

10,976 (98.8%)

9,515 (94.0%)

11,160 (99.3%)

6,317 (99.2%)

9,860 (93.7%)

10,088 (91.5%)

4,916 (95.5%)

3,873 (91.5%)

9,149 (83.6%)

SorI:1 (0.0%)

I:219 (2.0%)

I:28 (0.3%)

I:235 (2.3%)

I:23 (0.2%)

I:7 (0.1%)

I:327 (3.1%)

I:430 (3.9%)

I:59 (1.1%)

I:132 (3.1%)

1,265 (11.6%)

IorR:1 (0.0%)

IorR:4 (0.0%)

IorR:1 (0.0%)

IorR:116 (1.1%)

IorR:10 (0.2%)

R:513 (5.7%)

R:322 (2.9%)

R:102 (0.9%)

R:371 (3.7%)

R:24 (0.2%)

R:38 (0.6%)

R:328 (3.1%)

R:388 (3.5%)

R:174 (3.4%)

R:220 (5.2%)

R:526 (4.8%)

判定不能:8 (0.1%)

判定不能:27 (0.2%)

判定不能:2 (0.0%)

判定不能:7 (0.1%)

判定不能:1 (0.0%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

PIPC (N=10,940)

TAZ/PIPC (N=4,235)

SBT/ABPC (N=5,150)

CAZ (N=11,023)

CFPM (N=10,522)

IPM (N=6,365)

MEPM (N=11,238)

GM (N=10,121)

AMK (N=11,106)

LVFX (N=11,033)

ST (N=8,938)



2019年07⽉18⽇

外来検体で、かつ検査法が微量液体希釈法⼜はEtestと設定されMIC値が報告されている検体を集計抗菌薬感受性結果の重複処理(巻末参照)が⾏われている*S,I,Rの判定はCLSI 2012 (M100-S22）に準拠†菌名コード︓4400〜4403と報告された菌集計株数が30株未満の場合には、集計結果を公表しない

22




【外来検体】


Haemophilus influenzae†


2019年07⽉18⽇

24,981 (99.0%)

51,641 (81.9%)

31,378 (81.0%)

37,990 (65.7%)

26,603 (38.6%)

I:80 (0.3%)

9,132 (14.5%)

13,388 (19.4%)

IorR:1 (0.0%)

IorR:181 (0.3%)

IorR:1 (0.0%)

R:164 (0.7%)

R:1,701 (2.7%)

7,332 (18.9%)

19,800 (34.3%)

29,013 (42.0%)

判定不能:377 (0.6%)

判定不能:6 (0.0%)

判定不能:2 (0.0%)

判定不能:1 (0.0%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

ABPC (N=69,006)

SBT/ABPC (N=57,792)

CVA/AMPC (N=38,716)

CAM (N=63,032)

TC (N=25,226)


67,990 (99.3%)

66,244 (96.7%)

49,313 (98.9%)

NS:479 (0.7%)

NS:2,256 (3.3%)

NS:549 (1.1%)

判定不能:1 (0.0%)

判定不能:1 (0.0%)

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

CTX (N=49,862)

MEPM (N=68,501)

LVFX (N=68,470)


外来検体で、かつ検査法が微量液体希釈法⼜はEtestと設定されMIC値が報告されている検体を集計抗菌薬感受性結果の重複処理(巻末参照)が⾏われている*S,I,RまたはS,NSの判定はCLSI 2012 (M100-S22）に準拠†菌名コード︓3201, 3202, 3203, 3205, 3208, 3211, 3214, 3217, 3220, 3223と報告された菌集計株数が30株未満の場合には、集計結果を公表しない

23




【外来検体】

【巻末資料外来検体の集計方法について】

A菌 A菌 B菌 A菌 B菌 C菌

1. 主要菌の菌名コード

菌名菌名コード Ver.5.1 Staphylococcus aureus（ALL） 1301，1303-1306

Staphylococcus aureus（MSSA） 1301，1304-1306 と報告され MPIPC およびCFXが “S”（一方が未測定の場合も含む）

Staphylococcus aureus（MRSA） 1301，1303と報告されMPIPCまたは CFXが “R”

Staphylococcus epidermidis 1312 Coagulase-negative staphylococci（CNS） 1311,1313-1325 Enterococcus faecalis 1201,1202 Enterococcus faecium 1205,1206 Streptococcus pneumoniae 1131 Streptococcus pyogenes 1111 Streptococcus agalactiae 1114 Escherichia coli 2001-2007 Klebsiella pneumoniae 2351 Enterobacter cloacae 2151 Klebsiella (Enterobacter) aerogenes 2152 Citrobacter freundii 2051 Citrobacter koseri 2052 Proteus mirabilis 2201 Proteus vulgaris 2202 Serratia marcescens 2101 Pseudomonas aeruginosa 4001 Acinetobacter spp. 4400-4403

Haemophilus influenzae 3201-3203,3205,3208,3211, 3214, 3217,3220,3223

※ S,I,Rおよび S,NSの判定は CLSI 2012（M100-S22）に準拠

2. 抗菌薬感受性の重複処理

同一患者から同一菌の抗菌薬感受性結果が複数回報告された場合は、検査材料、抗菌薬感受性結果にかかわらず、初回の 1件のみ集計する。同一患者から異なる菌の抗菌薬感受性結果が報告された場合は、それぞれ初回の 1件のみ集計する。例）

3月上旬 3月下旬 10月

同一患者 × × × 集計 A菌：2度目の報告のため集計しない

B菌：初回の報告のため集計 A菌：3度目の報告のため集計しない B菌：2度目の報告のため集計しない C菌：初回の報告のため集計

Documents

院内感染対策サーベイランス 検査部⾨ 【外来検体】 7．主要 …...2018/03/01 · 7．主要菌の抗菌薬感受性* Staphylococcus aureus(ALL)† 公開情報

院内感染対策サーベイランス検査部⾨【外来検体】 7．主要 …...2018/03/01 · 7．主要菌の抗菌薬感受性* Staphylococcus aureus(ALL)† 公開情報